Stylized first-aid kit and medical icons sitting on a rising stock chart, symbolizing Johnson & Johnson’s AAA strength and insider buying in JNJ shares.

Director Purchases Shares of Johnson & Johnson

A director just slapped fresh cash on Johnson & Johnson stock. With a AAA credit rating, a 100+ year history, blockbuster drugs, cutting-edge MedTech, and a valuation that’s more “fair” than “fire sale,” should retail investors follow—or wait for a better entry point?

Read entire article